1-6 of 6
Byung Gyu Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Whole-Exome Sequencing Identifies a Somatic Cell Mutation Signature That Predicts Relapse Risk and Survival Probability in Multiple Myeloma

Ehsan Malek, MD, E. Ricky Chan, PhD, Daniel Qu, Jane Reese, Robert Fox, Byung-Gyu Kim, PhD DVM, Paolo F Caimi, MD, Marcos de Lima, MD, James J. Driscoll, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 5.
https://doi.org/10.1182/blood-2020-142791
Published: 2020
Journal Articles

Preclinical Studies and a Phase I Trial of the TGF-β Receptor Inhibitor, Vactosertib (TEW-7197), in Combination with Pomalidomide in Patients with Multiple Myeloma Refractory to Bortezomib or Lenalidomide

Ehsan Malek, MD, Byung-Gyu Kim, PhD DVM, Jason Valent, MD, James Driscoll, MD PhD, Paolo Caimi, MD, Seong-Jin Kim, PhD, Marcos de Lima, MD, John Letterio, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1962.
https://doi.org/10.1182/blood-2018-99-112449
Published: 2018
Journal Articles

Vactosertib, a TGF-ß Receptor I Kinase/ALK5 Inhibitor, Diminishes Tumor Progression and Bone Disease in a Mouse Model of Multiple Myeloma and Overcomes Resistance to Proteasome Inhibitors

Byung-Gyu Kim, PhD DVM, Sung Hee Choi, PhD, George Luo, Olga Sergeeva, PhD, Zhenghong Lee, PhD, James Driscoll, MD PhD, Marcos de Lima, MD, Rose Beck, MD PhD, Seong-Jin Kim, PhD, John Letterio, MD, Ehsan Malek, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1918.
https://doi.org/10.1182/blood-2018-99-117852
Published: 2018
Journal Articles

Defining a Bone Marrow Immune Signature Associated with Immunoglobulin Isotype Switching after Autologous Stem Cell Transplant

Rebecca Ye, Sirisha Kundrapu, Stanton L. Gerson, MD, Rose Beck, MD PhD, James Driscoll, MD PhD, Suchitra Sundaram, MBBS, Byung-Gyu Kim, PhD DVM, Willem vanHeeckeren, Marcos De Lima, MD, Ehsan Malek, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3038.
https://doi.org/10.1182/blood.V130.Suppl_1.3038.3038
Published: 2017
Journal Articles

Rethinking Risk-Benefit Assessment for Phase I Multiple Myeloma Trials

Ehsan Malek, MD, Caner Saygin, MD, Rebecca Ye, Byung-gyu Kim, DVM, Fahrettin Covut, MD, Marcos De Lima, MD, James J. Driscoll, MD PhD
Journal: Blood
Blood (2016) 128 (22): 1146.
https://doi.org/10.1182/blood.V128.22.1146.1146
Published: 2016
Journal Articles

Identification of a Novel and Efficacious Oral Proteasome Inhibitor As a Potential Clinical Development Candidate

Kwang-Ai Won, PhD, Byung Gyu Kim, Cheol-Kyu Jung, Eok Park, Eunbok Baek, Jonghoon Park, Seung-Wan Kang, Tae Hun Kim, Youngjoo Jung
Journal: Blood
Blood (2014) 124 (21): 4808.
https://doi.org/10.1182/blood.V124.21.4808.4808
Published: 2014